Colonic stent for ‘Bridge to Surgery’ prospective randomized controlled trial comparing treatment with non-stenting surgery in stage II/III obstructive colon cancer

Interventions: Colonic stenting within 7 days and primary tumor resection within 3-30 days after allocation
After management by fasting or liquid intake, primary tumor resection within 3-30 days after allocation
Primary outcome(s): Disease-free survival at 3 years
Study Design: Parallel Randomized